Prescription drug · ANDA
Brivaracetam Oral Solution (Brivaracetam) NDC 67877-904
Brivaracetam 10 mg/mL · Solution · Oral · Ascend Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67877-904-58 | 6787709045867877090458 | 1 BOTTLE in 1 CARTON (67877-904-58) / 300 mL in 1 BOTTLEMarketed from Feb 23, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brivaracetam Oral Solution
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 10 mg/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Ascend Laboratories, LLCNDC labeler code 67877
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219772
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 67877-904_83ea212f-3496-4230-bf18-02bd6c82038fSPL ID 83ea212f-3496-4230-bf18-02bd6c82038fSPL set ID c4ee9b82-1067-4efc-b3d9-f24eb0c461d5RxCUI 1739785UNII U863JGG2IAUPC 0367877904580
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467877090458followed by a unit qualifier and the quantityPackage 67877-0904-58. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 67877-904
- What is NDC 67877-904?
- 67877-904 is the product NDC for Brivaracetam Oral Solution (brivaracetam), Brivaracetam 10 mg/mL solution, listed with the FDA by Ascend Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Brivaracetam Oral Solution (Brivaracetam).
- What is the active ingredient?
- Brivaracetam.
- Who is the labeler?
- Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Brivaracetam Oral Solution?
- 1 other product NDC are listed under this name. See all Brivaracetam Oral Solution NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Brivaracetam Oral Solution products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Brivaracetam oral Solutionbrivaracetam oral | Brivaracetam 10 mg/mL | SolutionOral | Florida Pharmaceutical Products, LLC | 71921-410 | 71921-0410-72 |